Literature DB >> 19019641

Optic nerve sheath meningiomas--non-surgical treatment.

R I Smee1, M Schneider, J R Williams.   

Abstract

AIMS: Optic nerve sheath meningiomas typically present with unilateral visual deterioration. Here, a single centre's experience with radiotherapy aimed at local control and visual stabilisation is presented.
MATERIALS AND METHODS: The meningioma database within the Radiation Oncology Department, Prince of Wales Hospital was audited for patients whose meningiomas took origin from the optic nerve sheath. Excluded from this evaluation was any patient whose meningioma secondarily involved the optic nerve. Where vision was not a consideration, treatment was given by stereotactic radiosurgery for patients with retained vision. The remaining patients were treated by fractionated radiotherapy, predominately via a stereotactic approach. The main end points were: lack of radiological progression of the tumour and maintenance of preradiotherapy vision.
RESULTS: There were 15 eligible patients, one patient with neurofibromatosis had bilateral optic nerve involvement; thus, 16 optic nerves were treated. Women (10) outnumbered men (five) and the age range was 7-74 years. One patient progressed outside the volume treated (for a geographical failure) with no infield progression. This patient became blind, was re-treated by stereotactic radiosurgery, had tumour control and vision improved. Thus, for 17 optic nerves (or part thereof) treated, all patients ultimately had local control (100%) with worsening of vision only occurring in one patient. No other late morbidity was present for any patient.
CONCLUSION: Optic nerve sheath meningiomas have high local control rates and preservation of vision with radiotherapy.

Entities:  

Mesh:

Year:  2008        PMID: 19019641     DOI: 10.1016/j.clon.2008.10.010

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  9 in total

Review 1.  Fractionated radiotherapy for intracranial meningiomas.

Authors:  Vinai Gondi; Wolfgang A Tome; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

2.  Primary and Secondary Optic Nerve Sheath Meningioma.

Authors:  Elena Solli; Roger E Turbin
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

3.  Efficacy of intensity-modulated radiation therapy for optic nerve sheath meningioma.

Authors:  Hiroyuki Sasano; Keigo Shikishima; Manabu Aoki; Tsutomu Sakai; Yuki Tsutsumi; Tadashi Nakano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-03       Impact factor: 3.117

4.  Analyses on the misdiagnoses of 25 patients with unilateral optic nerve sheath meningioma.

Authors:  Jun-Feng Mao; Xiao-Bo Xia; Xiang-Bo Tang; Xue-Yong Zhang; Dan Wen
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

5.  Radiation Associated Meningiomas:The Case for Repeat Radiotherapy.

Authors:  Robert I Smee
Journal:  J Radiosurg SBRT       Date:  2011

6.  Optic nerve sheath meningioma detected by single- photon emission computed tomography/computed tomography somatostatin receptor scintigraphy: a case report.

Authors:  Lucie Nussbaum-Hermassi; Guido Ahle; Chistophe Zaenker; Camelia Duca; Izzie Jacques Namer
Journal:  J Med Case Rep       Date:  2016-04-22

Review 7.  Optic nerve sheath meningiomas: prevalence, impact, and management strategies.

Authors:  Richard T Parker; Christopher A Ovens; Clare L Fraser; Chameen Samarawickrama
Journal:  Eye Brain       Date:  2018-10-24

8.  Long-Term Visual Function After Fractionated Stereotactic Radiotherapy for Primary Optic Nerve Sheath Meningioma: A Retrospective Analysis of 34 Subjects.

Authors:  Kavin Vanikieti; Chaloemwong Chaiwithooanukul; Putipun Puataweepong; Panitha Jindahra; Tanyatuth Padungkiatsagul
Journal:  Clin Ophthalmol       Date:  2022-09-22

9.  Optic Nerve Sheath Meningioma: Preliminary Analysis of the Role of Radiation Therapy.

Authors:  Jun Jin; Jin Deok Joo; Jung Ho Han; Hee Kyung Yang; Jeong Min Hwang; Yi Jun Kim; In Ah Kim; Chae Yong Kim
Journal:  Brain Tumor Res Treat       Date:  2018-04-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.